Hypercalcemia associated with eosinophilic myocarditis in a patient undergoing maintenance hemodialysis

Internal Medicine

Volumn 51, Issue 20, 2012, Pages 2913-2916

  Tanaka, Ken ichiro ^a   Yano, Shozo ^a   Okuyama, Keisuke ^a   Sato, Masatake ^a   Yamauchi, Mika ^a   Yamaguchi, Toru ^a   Tanabe, Kazuaki ^a   Himeno, Yasutoshi ^b   Sugimoto, Toshitsugu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b Himeno Clinic   (Japan)

Author keywords

Eosinophilic myocarditis; Hemodialysis; Hypercalcemia; Hypereosinophilic syndrome (HES); Steroid; Vitamin D

Indexed keywords

ALFACALCIDOL; BRAIN NATRIURETIC PEPTIDE; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; PARATHYROID HORMONE; PREDNISOLONE; VITAMIN D;

AGED; ANOREXIA; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DISEASE COURSE; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EOSINOPHILIA; HEART FAILURE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPEREOSINOPHILIC SYNDROME; HYPOKINESIA; KIDNEY FAILURE; MALE; MYOCARDITIS; NAUSEA; PLEURA EFFUSION; SINUS ARRHYTHMIA;

AGED; HUMANS; HYPERCALCEMIA; HYPEREOSINOPHILIC SYNDROME; MALE; MYOCARDITIS; RENAL DIALYSIS; VITAMIN D;

EID: 84867769435     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.8227     Document Type: Article

References (14)

1. Simon HU, Rothenberg ME, Bochner BS, et al. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 26: 45-49, 2010.
2. Ginsberg F, Parrillo JE. Eosinophilic myocarditis. Heart Fail Clin 1: 419-429, 2005.
3. Rothenberg ME. Eosinophilia. N Engl J Med 338: 1592-1600, 1998.
4. Nakanishi K, Kaneko T, Yano F, et al. Marked eosinophilia induced by nafamostat mesilate, an anticoagulant in a hemodialysis patient. Nephron 62: 97-99, 1992.
5. Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB. The prevalence and meaning of eosinophilia in renal diseases on a nephrology consultation service. Nephrol Dial Transplant 26: 2549-2558, 2011.
6. El-Shazly AE, Lefebvre PP. Modulation of NK cell autocrineinduced eosinophil chemotaxis by interleukin-15 and vitamin D (3): a possible NK-eosinophil crosstalk via IL-8 in the pathophysiology of allergic rhinitis. Mediators Inflamm 2011 Epub.
7. Matheu V, Back O, Mondoc E, Issazadeh-Navikas S. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J Allergy Clin Immunol 112: 585- 592, 2003.
8. Yanagisawa T, Inomata T, Watanabe I, et al. Clinical significance of corticosteroid therapy for eosinophilic myocarditis. Int Heart J 52: 110-113, 2011.
9. JCS Joint, Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009) digest version. Circ J 75: 734-743, 2011 Epub.
10. Gittman JE, Schneider G, Carnes RE, Arkel YS. Hypercalcemic crisis associated with the hypereosinophilic syndrome. Am J Med 64: 901-905, 1978.
11. Rutter MM, Prahalad S, Passo M, Backeljauw PF. Idiopathic hypercalcemia and eosinophilic fasciitis: a novel association. J Pediatr Endocrinol Metab 17: 1251-1254, 2004.
12. Sugimoto T, Ritter C, Morrissey J, Hayes C, Slatopolsky E. Effects of high concentrations of glucose on PTH secretion in parathyroid cells. Kidney Int 37: 1522-1527, 1990.
13. Inaba M, Nagasue K, Okuno S, et al. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus. Am J Kidney Dis 39: 1261-1269, 2002.
14. Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J 4: 643-646, 1973.